TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · major macro event coming up
FLGT

Fulgent Genetics Inc

Healthcare · Diagnostics & Research

22.20$ +3.0% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Balance Sheet

Fulgent Genetics Inc (FLGT) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 1,089 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios
Annual Quarterly
Amounts Change % Common size %
Last 12 Full history
Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet FLGT
Line item Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
23 58 59 59 59 57 56 56 55 55 56 56 61 89 89 96 247 700 999 1,050 1,205 1,279 1,466 1,462 1,406 1,386 1,377 1,355 1,358 1,235 1,230 1,232 1,234 1,220 1,206 1,200 1,215 1,214 1,156 1,089
13 51 33 50 48 45 44 43 43 43 43 44 49 37 37 41 196 524 659 567 623 612 765 675 697 628 581 528 550 508 387 399 327 354 417 429 507 550 479 455
8.2 7.9 6.7 11 9.5 6.5 5.3 3.7 8.5 6.7 5.3 9.2 21 12 9.3 2.4 53 87 151 100 215 165 353 139 169 80 66 58 84 97 55 65 58 55 67 88 118 50 23 26
8.2 46 27 46 44 41 39 38 37 37 38 39 44 28 27 21 75 299 410 384 470 450 585 515 571 526 504 458 468 424 306 312 213 258 320 293 376 336 276 257
4.4 4.4 4.6 4.2 3.7 4.1 5.0 5.1 6.1 6.2 4.6 5.6 5.4 7.2 6.9 15 101 204 219 153 126 143 165 138 108 75 48 40 55 57 59 64 65 77 80 85 79 92 76 71
0.5 0.3 0.5 0.3 0.3 0.2 0.4 0.4 0.3 0.3 0.4 0.4 0.2 0.3 1.5 2.2 18 16 26 25 22 12 11 12 7.5 4.3 4.7 5.5 4.9 5.8 6.5 7.0 8.6 8.4 8.6 9.0 10 11 12 12
5.2 6.2 5.9 6.7 6.5 7.3 6.9 7.3 6.9 6.4 8.9 8.7 9.1 8.6 8.2 8.8 17 40 47 53 60 62 69 86 82 99 79 88 – – – – – – – – – – – –
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 – – – – – – – – – – 23 49 51 51 121 120 143 143 142 142 22 22 22 22 22 22 22 25 25 54 54
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 – – – – – – – – – – 6.8 37 36 35 90 88 151 149 146 144 143 141 139 137 135 133 131 135 133 154 149
5.4 3.6 3.5 3.1 3.4 2.9 2.4 3.0 2.3 2.7 5.7 5.3 6.6 6.0 8.0 8.9 60 131 198 129 160 113 153 151 124 116 108 91 97 102 103 103 99 91 83 88 94 107 112 93
5.4 3.6 3.3 3.1 3.4 2.9 2.4 3.0 2.3 2.7 5.7 5.3 6.6 3.7 5.8 6.5 58 130 197 122 147 105 142 128 103 88 82 65 61 73 76 76 74 73 66 71 72 85 90 72
– – – – – – – – – – 0.4 0.4 0.4 0.4 0.4 0.5 0.5 15 15 16 17 21 21 21 20 27 21 4.6 2.9 5.1 3.3 2.7 1.9 1.9 1.8 1.7 2.0 1.9 2.4 2.3
3.3 2.8 2.3 1.8 2.4 2.1 1.3 1.8 1.0 1.3 1.5 1.2 2.2 1.6 2.9 3.6 19 26 17 15 25 20 24 37 14 23 22 21 16 15 20 20 20 18 18 19 18 19 21 16
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 – 2.5 – – – – – – – – 5.9 5.9 – – – – 3.4 – – – 3.0 2.5 2.5 2.5 2.5 2.0 2.0 2.0 2.0 1.5 1.5
17 54 55 56 55 54 53 53 53 52 50 51 55 83 81 87 187 569 802 913 1,037 1,159 1,306 1,305 1,277 1,267 1,264 1,260 1,259 1,136 1,130 1,133 1,138 1,133 1,127 1,117 1,126 1,112 1,050 1,002
-56 -55 -55 -55 -56 -58 -59 -60 -61 -63 -65 -65 -63 -63 -65 -62 -15 151 351 431 553 658 812 823 825 801 786 774 761 633 620 611 596 590 579 560 553 530 505 476
17 18 18 18 18 18 18 18 18 18 18 19 19 20 22 23 24 27 31 31 31 31 31 31 31 31 30 30 30 30 30 30 30 31 31 31 31 31 31 28

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?